
Scott D. Goldfarb, PharmD, MBA
Advertisement
Articles by Scott D. Goldfarb, PharmD, MBA
Advertisement
Latest Updated Articles
Economic Comparison of Oral Triptans for Management of Acute Migraine: Implications for Managed CarePublished: February 1st 2002 | Updated:
Almotriptan Versus Sumatriptan in Migraine Treatment: Direct Medical Costs of Managing Adverse Chest SymptomsPublished: February 1st 2002 | Updated:
Cost Savings in Migraine Associated with Less Chest Pain on New Triptan TherapyPublished: February 1st 2002 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
5 Things to Know About the Oral GLP-1 Era
5



